Novel therapies in Hepatitis C virus. Preface.
Pockros
Paul J
PJ
Division of Gastroenterology and Hepatology, The Scripps Research Institute, La Jolla, CA 92037, USA. pockros.paul@scrippshealth.org
D000998:Antiviral Agents / Q000627:therapeutic use; D055808:Drug Discovery; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a